Context‐specific anti‐inflammatory roles of type III interferon signaling in the lung in nonviral injuries
Physiological Reports · 2024-10 · 12 (20)
DOI: 10.14814/phy2.70104 ↗At a glance
Journal article in Physiological Reports, published online on 2024-10-25. Written by Jingjing Feng and 10 co-authors. Institution: Department of Pulmonary and Critical Care Medicine, Shanghai Fifth People's Hospital, Center of Community-Based Health Research, Fudan University, Sh…. Major MEDLINE topics: Signal Transduction, Mice, Inbred C57BL, Interferons, Bleomycin. Cited 2 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY 4.0). Funded by: Francis Family Foundation (FF), BLRD VA, NCATS NIH HHS.
Abstract (original language)
Type III interferons (λ1, λ2, and λ3) are potent antiviral cytokines in the lung. However, their roles in nonviral lung injuries are less well understood. This study investigates the activation of type III interferon signaling in three distinct models of lung injuries caused by diverse stimuli: the bacterial pathogen Pseudomonas aeruginosa, bacterial endotoxin LPS, and the chemotherapeutic agent bleomycin. Our data show that, despite inducing a potent inflammatory response, Pseudomonas and LPS did not increase IFNλ secretion. In contrast, bleomycin instillation increased secretion of IFNλ in the airways at both early and late time points. Consistent with limited secretion, type III interferon signaling had a minimal role in the host response to both Pseudomonas and LPS, as measured by pathogen burden, inflammatory response, and lung injury. Conversely, a deficiency in type III interferon signaling led to increased inflammatory signaling and elevated acute lung injury in the bleomycin model on day 3. This elevated early injury resulted in impaired recovery in IFNLR1 knockout mice, as evidenced by their recovery from bleomycin‐induced weight loss. Taken together, these data suggest a context‐specific activation of type III interferon signaling, where it plays an anti‐inflammatory role in the lung.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pulmonary and Critical Care Medicine, Shanghai Fifth People's Hospital, Center of Community-Based Health Research, Fudan University, Shanghai, China.
- Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
- Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Pulmonary and Critical Care Medicine at the Seventh Medical Center, College of Pulmonary and Critical Care Medicine of the Eighth Medical Center, Chinese PLA General Hospital, Beijing, China.
- Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.
- Department of Biochemistry and Molecular Biology, Rutgers New Jersey Medical School, New Brunswick, New Jersey, USA.
ORCID profiles: William G Bain, Lokesh Sharma
Funding
- Francis Family Foundation (FF)
- BLRD VA
- NCATS NIH HHS
- American Lung Association (ALA)
- U.S. Department of Defense (DOD)
- U.S. Department of Veterans Affairs (VA)
- NIAID NIH HHS
Cite
APA
Feng, J., Kim, J., Wang, V. D., Chang, Liu, H., Bain, W. G., Robinson, K. M., Jie, Z., Kotenko, S. V., Dela Cruz, C. S., & Sharma, L. (2024). Context‐specific anti‐inflammatory roles of type III interferon signaling in the lung in nonviral injuries. Physiological Reports, 12(20). https://doi.org/10.14814/phy2.70104
Vancouver
Feng J, Kim J, Wang VD, Chang, Liu H, Bain WG, et al. Context‐specific anti‐inflammatory roles of type III interferon signaling in the lung in nonviral injuries. Physiological Reports. 2024;12(20). doi:10.14814/phy2.70104
BibTeX
@article{Feng2024,
author = {Feng, Jingjing and Kim, Jooyoung and Wang, Victoria D and Chang, De and Liu, Hongbo and Bain, William G and Robinson, Keven M and Jie, Zhijun and Kotenko, Sergei V and Dela Cruz, Charles S and Sharma, Lokesh},
title = {Context‐specific anti‐inflammatory roles of type III interferon signaling in the lung in nonviral injuries},
journal = {Physiological Reports},
year = {2024},
volume = {12},
number = {20},
doi = {10.14814/phy2.70104}
}
EUVIMED